2m 2m 2m 2m 2m 2m 2m
ARCT THERAP HLDG (ARCT)
NASDAQ
$13.57+$0.12 (+0.92%)
Price as of Aug 21, 2026 7:59 PM EDT- $382.3MMarket Cap
- -27.34%1-Year Change
- BiotechnologyIndustry
ARCT THERAP HLDG (ARCT)
$13.57+$0.12 (+0.92%)
ARCT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $13.45 | ||
Change | +$2.46 (+22.38%) | ||
Open | $11.13 | ||
High | $13.50 | ||
Low | $11.11 | ||
Previous Close | $10.99 | ||
Volume | 2,856,256 | ||
30-Day Average Volume | 925,971 | ||
1-Week Change | 63.43% | ||
1-Month Change | 124.54% | ||
1-Year Change | -27.34% | ||
3-Year Change | -56.81% | ||
5-Year Change | -71.92% | ||
Fundamentals | |||
Shares Outstanding | 28.4M | ||
Total Assets | $224.3M | ||
Market Cap | $382.3M | ||
Enterprise Value | $190.8M | ||
Period: QTR TTM FY | |||
Revenue | $880,000.00 | ||
Net Income | -$23.8M | ||
Free Cash Flow | -$19.9M | ||
EBIT | -$23.8M | ||
EBITDA | -$23.1M | ||
Net Working Capital | $163.6M | ||
EPS | -$0.84 | ||
Enterprise Value/EBITDA | -8 | ||
Enterprise Value/Revenue | 217 | ||
P/B | 2 | ||
P/E | -16 | ||
PEG | -1 | ||
Price/Free Cash Flow | -19 | ||
Price/Operating Cash Flow | -19 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue